Alexandra Boogers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexandra Boogers has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Alfonso Fasano
Department of Biomedical Sciences Humanitas University Milan Italy
7 shared publications - Bart Nuttin
Department of Neurosurgery, University Hospitals Leuven, KU Leuven, Leuven, Belgium
3 shared publications - Jana Peeters
Experimental Oto-Rhino-Laryngology, Department of Neurosciences, KU Leuven, Belgium
3 shared publications - Myles Mc Laughlin
KU Leuven
3 shared publications - Philippe De Vloo
Department of Neurosurgery, University Hospitals Leuven, Leuven, Belgium
3 shared publications - Andres M. Lozano
University Health Network and University of Toronto
2 shared publications
Latest Publications
- Open Access
- 14 January 2026
- Published by Wiley in Movement Disorders
- Vol. 41 (4) , 1028-1033
Beta‐Band and Aperiodic Activity Across New and Chronic Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
Background: Neurophysiological biomarkers in Parkinson's disease (PD) are increasingly used for deep brain stimulation (DBS). Their long‐term utility is not clear, especially when transitioning to sensing‐guided DBS years post‐surgery. Objectives: Beta‐band power, bursting activity, and periodic and aperiodic components of local field potentials recorded from DBS electrodes in the subthalamic nucleus (STN) were compared between a group of newly and chronically (6.7 ± 4.0 years) implanted PD patients. Clinical severity was rated using the Movement Disorder Society‐Unified Parkinson's Disease Rating Scale‐Part III (MDS‐UPDRS‐III). Results: Beta‐band power and burst amplitude were significantly higher and aperiodic offset and exponent were significantly lower in the chronically implanted cohort. Periodic peak frequency and power were not significantly different. Clinical severity correlated with cumulative burst time and burst rate. A longitudinal subset showed no change in peak frequency or power. Conclusions: STN beta‐band‐related biomarkers inform disease state of de novo and chronic PD‐DBS cohorts, with signal properties relevant for sensing‐guided DBS preserved over time. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- 14 January 2026
- Published by Wiley in Movement Disorders
- Vol. 41 (4) , 1028-1033
Open AccessBeta‐Band and Aperiodic Activity Across New and Chronic Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
Background: Neurophysiological biomarkers in Parkinson's disease (PD) are increasingly used for deep brain stimulation (DBS). Their long‐term utility is not clear, especially when transitioning to sensing‐guided DBS years post‐surgery. Objectives: Beta‐band power, bursting activity, and periodic and aperiodic components of local field potentials recorded from DBS electrodes in the subthalamic nucleus (STN) were compared between a group of newly and chronically (6.7 ± 4.0 years) implanted PD patients. Clinical severity was rated using the Movement Disorder Society‐Unified Parkinson's Disease Rating Scale‐Part III (MDS‐UPDRS‐III). Results: Beta‐band power and burst amplitude were significantly higher and aperiodic offset and exponent were significantly lower in the chronically implanted cohort. Periodic peak frequency and power were not significantly different. Clinical severity correlated with cumulative burst time and burst rate. A longitudinal subset showed no change in peak frequency or power. Conclusions: STN beta‐band‐related biomarkers inform disease state of de novo and chronic PD‐DBS cohorts, with signal properties relevant for sensing‐guided DBS preserved over time. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- 16 November 2025
- Published by Springer Nature
- p. 79-93
The Sepsis Challenge: Breaking the Chain with a Cohesive Multimodal Strategy—A Nursing Perspective
- 16 November 2025
- Published by Springer Nature
- p. 79-93
The Sepsis Challenge: Breaking the Chain with a Cohesive Multimodal Strategy—A Nursing Perspective
- Open Access
- 28 July 2025
- Published by Ubiquity Press, Ltd. in Tremor and Other Hyperkinetic Movements
- Vol. 15 (1) , 33
Fixing a Shaky Video to Remotely Program Deep Brain Stimulation
Deep brain stimulation (DBS) is an increasingly utilized therapy for treating refractory tremor in Parkinson’s disease (PD). Remote care can improve patient access to specialized DBS clinics. Here, we present a novel strategy to assess tremor remotely during DBS programming. We report the case of a 65-year-old female diagnosed with PD who showed only partial responsiveness to levodopa. She underwent bilateral subthalamic nucleus DBS surgery and was implanted with an Infinity™ implantable pulse generator with directional leads (Abbott, Chicago, IL, USA). Given that she resided 1,500 km from our center, device programming was performed remotely using the Neurosphere™ Virtual Clinic platform. The patient was instructed to hold her controller in a fixed position until her resting tremor re-emerged, which was visibly evident through a shaking video frame. Stimulation parameters were then optimized until the video frame became still. She reported sustained benefit during follow-up. We propose that this alternative method for remotely assessing upper limb tremor may offer advantages for healthcare providers, allowing them to base stimulation adjustments on visually observable tremor severity.
- 28 July 2025
- Published by Ubiquity Press, Ltd. in Tremor and Other Hyperkinetic Movements
- Vol. 15 (1) , 33
Open AccessFixing a Shaky Video to Remotely Program Deep Brain Stimulation
Deep brain stimulation (DBS) is an increasingly utilized therapy for treating refractory tremor in Parkinson’s disease (PD). Remote care can improve patient access to specialized DBS clinics. Here, we present a novel strategy to assess tremor remotely during DBS programming. We report the case of a 65-year-old female diagnosed with PD who showed only partial responsiveness to levodopa. She underwent bilateral subthalamic nucleus DBS surgery and was implanted with an Infinity™ implantable pulse generator with directional leads (Abbott, Chicago, IL, USA). Given that she resided 1,500 km from our center, device programming was performed remotely using the Neurosphere™ Virtual Clinic platform. The patient was instructed to hold her controller in a fixed position until her resting tremor re-emerged, which was visibly evident through a shaking video frame. Stimulation parameters were then optimized until the video frame became still. She reported sustained benefit during follow-up. We propose that this alternative method for remotely assessing upper limb tremor may offer advantages for healthcare providers, allowing them to base stimulation adjustments on visually observable tremor severity.
- Open Access
- 30 April 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 12 (8) , 1173-1180
Tics and Parkinson's Disease: Clinical and Pathophysiological Insights from a Rare Syndromic Association
Background: The coexistence of tics with Parkinson's disease (PD) is rare, as they often emerge at different ages, follow different trajectories and involve contrasting pathophysiological mechanisms related to dopamine availability and function in the brain.Cases: We present 10 individuals with primary tic disorders who later developed PD. Tic severity remained unchanged with the onset of parkinsonism or dopaminergic treatment. Peak‐dose dyskinesias in two cases did not affect tics, and deep brain stimulation of the subthalamic nucleus transiently induced tics in one individual with PD.Conclusions: The evidence drawn from this case series does not support a linear relation between nigrostriatal dopaminergic availability and tics. It suggests that tics may instead arise from a more complex interplay between multiple neurotransmitter systems acting on several networks within the cortico‐striatal‐thalamic circuits.
- 30 April 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 12 (8) , 1173-1180
Open AccessTics and Parkinson's Disease: Clinical and Pathophysiological Insights from a Rare Syndromic Association
Background: The coexistence of tics with Parkinson's disease (PD) is rare, as they often emerge at different ages, follow different trajectories and involve contrasting pathophysiological mechanisms related to dopamine availability and function in the brain.Cases: We present 10 individuals with primary tic disorders who later developed PD. Tic severity remained unchanged with the onset of parkinsonism or dopaminergic treatment. Peak‐dose dyskinesias in two cases did not affect tics, and deep brain stimulation of the subthalamic nucleus transiently induced tics in one individual with PD.Conclusions: The evidence drawn from this case series does not support a linear relation between nigrostriatal dopaminergic availability and tics. It suggests that tics may instead arise from a more complex interplay between multiple neurotransmitter systems acting on several networks within the cortico‐striatal‐thalamic circuits.
- Open Access
- 11 March 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 12 (7) , 1020-1023
Rhythmic Eyelid Closure Responsive to STN‐DBS: Blepharoclonus, Blepharospasm, Eyelid Opening Apraxia, or Eyelid Tremor?
- 11 March 2025
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 12 (7) , 1020-1023
Open AccessRhythmic Eyelid Closure Responsive to STN‐DBS: Blepharoclonus, Blepharospasm, Eyelid Opening Apraxia, or Eyelid Tremor?
- 1 February 2025
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 15 (1) , e200367
Functional Movement Disorders and Deep Brain Stimulation
The aim of this narrative review was to explore the interplay between functional movement disorders (FMDs) and deep brain stimulation (DBS). Patients with unrecognized FMD who are referred for DBS usually present with functional dystonia. By contrast, patients who present with FMD after DBS are mostly presenting with functional tremor, in keeping with non-DBS FMD cohorts. Comorbid presentation of FMD in established DBS indications makes the decision to opt for surgery challenging. Many contributing factors can play a role in the development of FMD, including the trauma caused by awake neurosurgery and/or extensive DBS programming. FMDs in the context of DBS are often overlooked and should be diagnosed promptly because they determine surgical outcome. The approach to DBS candidates with comorbid FMD and the risk factors of FMD after DBS should be further explored.
- 1 February 2025
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 15 (1) , e200367
Functional Movement Disorders and Deep Brain Stimulation
The aim of this narrative review was to explore the interplay between functional movement disorders (FMDs) and deep brain stimulation (DBS). Patients with unrecognized FMD who are referred for DBS usually present with functional dystonia. By contrast, patients who present with FMD after DBS are mostly presenting with functional tremor, in keeping with non-DBS FMD cohorts. Comorbid presentation of FMD in established DBS indications makes the decision to opt for surgery challenging. Many contributing factors can play a role in the development of FMD, including the trauma caused by awake neurosurgery and/or extensive DBS programming. FMDs in the context of DBS are often overlooked and should be diagnosed promptly because they determine surgical outcome. The approach to DBS candidates with comorbid FMD and the risk factors of FMD after DBS should be further explored.
- Open Access
Modulation of inhibitory synaptic plasticity for restoration of basal ganglia dynamics in Parkinson’s disease
Introduction: Parkinson’s disease is characterized, in part, by hypoactivity of both direct pathway inhibitory projections from striatum to the globus pallidus internus (GPi) and indirect pathway inhibitory projections from globus pallidus externus (GPe) to the subthalamic nucleus (STN), giving rise to disrupted basal ganglia circuit activity. In this study, we explored the use of intracranial stimulation for eliciting long-term potentiation (LTP) of each of these pathologically underactive inhibitory projections for the restoration of basal ganglia circuit dynamics and amelioration of motor symptoms. Methods: Data were collected from a total of 31 people with Parkinson’s disease (42 hemispheres). During deep brain stimulation (DBS) surgery, we assessed microelectrode stimulation-induced changes to inhibitory evoked field potentials (fEP) and hand kinematics before versus after a 40-second train of high-frequency stimulation (HFS) in the GPi (n = 7, 11 sites at 100 Hz) and STN (n = 10, 14 sites at 100 Hz; n = 4, 7 sites at 180 Hz). Additionally, we assessed changes to beta oscillations and hand kinematics in people with chronic DBS implants in the GPi (n = 6 at 125 Hz) and STN (n = 4 at 180 Hz). Results: Intraoperatively, increases in fEP amplitude (p = 0.002) and improved motor performance (p = 0.003) were observed after 100 Hz HFS in the GPi; while in STN, HFS did not potentiate fEPs (p = 0.589) or improve motor performance (p = 0.460) (similar results yielded for 180 Hz in STN). Similarly, extraoperative GPi-DBS produced suppression of beta power (p=0.096) and motor improvement (p = 0.077) before versus after HFS at 125 Hz; while STN-DBS at 180 Hz did not significantly affect beta power (p = 0.267) or motor performance (p=0.850). Interpretation: Our findings support that LTP-like effects in GPi may produce motor improvements that extend beyond stimulation cessation, aligning with optogenetic studies showing long-lasting motor recovery through periodic D1-striatal activation in rodents. The lack of effects in STN suggests that stimulation paradigms may require optimization for effective LTP induction. These findings nevertheless highlight the potential of LTP-based strategies for sustained therapeutic benefits in Parkinson’s disease, warranting further investigation into periodic stimulation paradigms for optimizing DBS efficacy and side effect profiles.
Open AccessModulation of inhibitory synaptic plasticity for restoration of basal ganglia dynamics in Parkinson’s disease
Introduction: Parkinson’s disease is characterized, in part, by hypoactivity of both direct pathway inhibitory projections from striatum to the globus pallidus internus (GPi) and indirect pathway inhibitory projections from globus pallidus externus (GPe) to the subthalamic nucleus (STN), giving rise to disrupted basal ganglia circuit activity. In this study, we explored the use of intracranial stimulation for eliciting long-term potentiation (LTP) of each of these pathologically underactive inhibitory projections for the restoration of basal ganglia circuit dynamics and amelioration of motor symptoms. Methods: Data were collected from a total of 31 people with Parkinson’s disease (42 hemispheres). During deep brain stimulation (DBS) surgery, we assessed microelectrode stimulation-induced changes to inhibitory evoked field potentials (fEP) and hand kinematics before versus after a 40-second train of high-frequency stimulation (HFS) in the GPi (n = 7, 11 sites at 100 Hz) and STN (n = 10, 14 sites at 100 Hz; n = 4, 7 sites at 180 Hz). Additionally, we assessed changes to beta oscillations and hand kinematics in people with chronic DBS implants in the GPi (n = 6 at 125 Hz) and STN (n = 4 at 180 Hz). Results: Intraoperatively, increases in fEP amplitude (p = 0.002) and improved motor performance (p = 0.003) were observed after 100 Hz HFS in the GPi; while in STN, HFS did not potentiate fEPs (p = 0.589) or improve motor performance (p = 0.460) (similar results yielded for 180 Hz in STN). Similarly, extraoperative GPi-DBS produced suppression of beta power (p=0.096) and motor improvement (p = 0.077) before versus after HFS at 125 Hz; while STN-DBS at 180 Hz did not significantly affect beta power (p = 0.267) or motor performance (p=0.850). Interpretation: Our findings support that LTP-like effects in GPi may produce motor improvements that extend beyond stimulation cessation, aligning with optogenetic studies showing long-lasting motor recovery through periodic D1-striatal activation in rodents. The lack of effects in STN suggests that stimulation paradigms may require optimization for effective LTP induction. These findings nevertheless highlight the potential of LTP-based strategies for sustained therapeutic benefits in Parkinson’s disease, warranting further investigation into periodic stimulation paradigms for optimizing DBS efficacy and side effect profiles.
- 25 April 2024
- Published by Wiley in Movement Disorders
- Vol. 39 (4) , 761
Reply to: Comment on: A Transatlantic Viewpoint on the Role of Pallidal Stimulation for Parkinson's Disease
- 25 April 2024
- Published by Wiley in Movement Disorders
- Vol. 39 (4) , 761
Reply to: Comment on: A Transatlantic Viewpoint on the Role of Pallidal Stimulation for Parkinson's Disease
- 8 May 2023
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 111, 105435
Acute stimulation with symmetric biphasic pulses induces less ataxia compared to cathodic pulses in DBS for essential tremor
- 8 May 2023
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 111, 105435
Acute stimulation with symmetric biphasic pulses induces less ataxia compared to cathodic pulses in DBS for essential tremor
- Open Access
- 15 February 2023
- Published by Elsevier in Brain Stimulation
- Vol. 16 (1) , 269
Development and evaluation of LFP evoked potential based biomarkers in subthalamic deep brain stimulation
- 15 February 2023
- Published by Elsevier in Brain Stimulation
- Vol. 16 (1) , 269
Open AccessDevelopment and evaluation of LFP evoked potential based biomarkers in subthalamic deep brain stimulation